AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jin Gang, M.D.
Changhai Hospital
Study Chair - Wang Bei Lei, M.D.
Changhai Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shanghai Changhai Hospital
Shanghai, Shanghai Municipality, China
Jin Gang, M.D.Wang Bei Lei, M.D.Recruiting - Second Affiliated Hospital of Jiaxing University
Jiaxing, Zhejiang, China
Shen Yi Jue, M.D.Recruiting - Yinzhou Hospital Affiliated To Medical School of Ningbo University
Ningbo, Zhejiang, China
Zhu Ke Lei, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Aug 2024
- Primary completion
- 31 Dec 2029
- Completion
- 31 Dec 2030
- Last update posted
- 19 Mar 2025
- Registered enrollment
- 5,000
- Registry id
- NCT06638866
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.